Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Millions wait for transplants — together, we can bring hope to life

Millions wait for transplants — together, we can bring hope to life

What is Xenotransplantation?

Concept

Transplanting animal-derived organs, tissues, or cells into humans


Types

Solid organs (e.g., kidney, liver, heart), biological tissues, and cellular therapies


Core Value

Addressing the critical global shortage of transplantable human organs

What is Xenotransplantation?
Why Choose Pigs for Xenotransplantation?

Pigs are considered ideal organ donors for xenotransplantation

  • Comparable organ size, and physiological compatibility with humans

  • High genetic tractability and rapid reproductive cycle

  • Lower ethical concerns compared to non-human primates, with manageable risk of zoonotic disease transmission

  • Well-established husbandry practices ensure a stable and reliable medical-grade organ supply

Why Choose Pigs for Xenotransplantation?
About ClonOrgan
China's Leading Xenotransplantation Enterprise

ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs;

Cultivating China's largest population of gene-edited, low-immunogenicity donor pigs;

Developing therapeutic technologies using transplantable pig organs and tissues, including kidneys, livers, hearts, skin, red blood cells.

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Shaoping Deng

    Professor Shaoping Deng

News
Company News
Media Coverage
Science Outreach
Science Literature
  • 猪-猴肾移植存活超500天,跻身国际一流

    2026/03/13 Company News
    近日,由华中科技大学同济医学院附属同济医院陈刚教授团队、海南医科大学附属第二医院王毅教授团队与中科奥格生物科技有限公司合作开展的基因编辑猪肾到猴移植实验存活超过500天,受体猴状态良好,猪肾功能维持稳定。这是亚洲第一例存活超过500天的猪-猴肾移植实验,为推进异种肾移植向临床转化积累了关键数据。目前有文献报道的存活超过500天的猪-猴移植实验均由美国团队完成,其中最长纪录是2023年eGenesi...
  • 再次登上《Nature》新闻,中科奥格持续助力异种肝移植临床突破

    2026/03/10 Company News
    近日,《Nature》杂志新闻页发表题为《Genetically modified pig liver keeps man alive until human organ transplant》的文章,报道了空军军医大学西京医院窦科峰院士团队领衔完成的一项全球首创临床研究:将基因编辑猪肝体外灌注应用于治疗肝衰竭患者。接受治疗的是一名56岁慢加急性肝衰竭患者。患者血液通过体外灌注系统流经基因编辑猪肝...